On 24 June 2015 the French Cycling Federation (FCC) Appeal Panel decided to impose a 1 year period of ineligibility on the cyclist after his sample tested positive for the prohibited substance Triamcinolone acetonide.
Hereafter the case was reopened by the French Anti-Doping Agency (AFLD). Following notification the Athlete filed a statement in his defence and failed to attend the hearing.
The AFLD finds that the presence of a prohibited substance has been established in the Athlete's sample and accordingly that he committed an anti-doping rule violation.
The AFLD determines that the Athlete had mentioned his medication on th Doping Control Form and that his application for a TUE was denied in March 2015. The AFLD deems that the Athlete failed to explain how he obtained this medication, nor did he provide a medical justification for the use of this medication.
Therefore the AFLD decides on 7 January 2016 to impose a 2 year period of ineligiblity on the Athlete.
